• Autophagy-Liver Metastasis Signature Refines CRC Prognosis

  2026-05-11

  Bai et al. (2026) developed and validated a colorectal cancer prognostic signature by integrating autophagy- and liver metastasis-related genes. This work links immune microenvironment dynamics to prognostic prediction, informing future research in tumor biology and therapeutic response.

• EGTA (3,12-bis(carboxymethyl)-6,9-dioxa-3,12-diazatetradecan

  2026-05-11

  This article addresses key laboratory challenges in cell viability, proliferation, and cytotoxicity assays by showcasing how 'EGTA (3,12-bis(carboxymethyl)-6,9-dioxa-3,12-diazatetradecane-1,14-dioic acid)' (SKU B7195) delivers reproducible, selective calcium chelation. Practical Q&A scenarios guide researchers toward evidence-backed solutions, emphasizing the unique value, purity, and workflow compatibility of APExBIO's EGTA.

• Wnt Agonist 1 (BML-284): Precision Modulation and Chemoresis

  2026-05-10

  Discover how Wnt agonist 1 (BML-284) enables refined control of canonical Wnt signaling and offers new perspectives on chemoresistance. This article delivers advanced analysis of Wnt pathway activation for cellular differentiation research, grounded in recent translational findings.

• Arrb2 Drives M2 Macrophage Polarization to Mitigate Liver IR

  2026-05-09

  This study identifies hepatocyte Arrb2 as a key regulator of M2 macrophage polarization via upregulation of the metabolite 6-ketoLCA, effectively reducing hepatic ischemia–reperfusion injury (IRI). The findings highlight a novel hepatocyte–immune cell interaction pathway and suggest new directions for liver transplantation outcome improvement.

• Chemotactic Crawling of Vesicles: DNA-Mediated Multivalent A

  2026-05-08

  This study provides experimental and theoretical insight into the chemotactic motion of artificial lipid vesicles that crawl along ligand-density gradients using DNA-mediated multivalent adhesion. The findings clarify the roles of binding strength and vesicle size in controlling directed movement, offering design principles relevant to synthetic biology and biomimetic motile systems.

• Filipin III: Polyene Macrolide Antibiotic for Cholesterol De

  2026-05-08

  Filipin III, a polyene macrolide antibiotic, empowers high-resolution cholesterol detection in biological membranes. This article decodes the best-practice workflows, advanced troubleshooting, and unique assay advantages that APExBIO’s Filipin III (SKU B6034) brings to membrane biology and translational research.

• Hoechst 33258: Precision DNA Staining in Tumor pH Modulation

  2026-05-07

  Explore the advanced application of Hoechst 33258 as a bis-benzimide DNA stain for precise DNA visualization and cell cycle analysis in tumor pH modulation studies. This article reveals unique insights into assay design and workflow optimization, elevating your research beyond standard protocols.

• IR-1061: Accelerating Precision Deep Tissue Molecular Imagin

  2026-05-07

  This thought-leadership article explores the pivotal role of IR-1061, a next-generation near infrared fluorescent dye, in elevating deep tissue imaging for translational biomedical research. By integrating mechanistic insights from the latest nanocatalytic therapy advances and practical guidance on workflow optimization, the article offers a strategic roadmap for researchers seeking to harness the full translational potential of IR-1061. Distinct from standard product guides, it critically examines cross-disciplinary evidence, protocol design, and competitive positioning, with a focus on long-term impact and responsible innovation.

• CUDC-907: Practical Guidance for Dual PI3K and HDAC Inhibiti

  2026-05-06

  CUDC-907 is a dual PI3K and HDAC inhibitor designed for precise in vitro modulation of cancer cell signaling, cell cycle, and apoptosis pathways. This compound addresses the need for simultaneous pathway inhibition in cell-based assays but is not validated for diagnostic or clinical applications.

• Vidarabine Monohydrate: Structural Insights and Research Fro

  2026-05-06

  Explore the unique structural and mechanistic characteristics of Vidarabine monohydrate, a pivotal antiviral research compound. This in-depth analysis clarifies its molecular action and solubility, offering advanced perspectives beyond standard protocols.

• Filipin III: Precision Cholesterol Detection in Membrane Res

  2026-05-05

  Filipin III, a leading polyene macrolide antibiotic from APExBIO, empowers researchers with unparalleled specificity in cholesterol detection within biological membranes. This article delivers actionable workflows, troubleshooting insights, and leverages novel findings on cholesterol homeostasis in metabolic disease models for optimized assay design.

• Biotin-tyramide: Technical Guidelines for TSA Signal Amplifi

  2026-05-05

  Biotin-tyramide (SKU A8011) is a specialized biotin phenol reagent engineered for robust, enzyme-mediated signal amplification in immunohistochemistry (IHC) and in situ hybridization (ISH) workflows. It offers precise biotin deposition via HRP catalysis, supporting both chromogenic and fluorescence detection. Researchers should avoid using this reagent for applications outside fixed-cell or tissue protocols, and ensure compatibility with DMSO or ethanol-based solubilization.

• Prednisone in Bench Research: Applied Workflows & Troublesho

  2026-05-04

  Prednisone, a synthetic corticosteroid, offers robust immunosuppressive and apoptotic control in translational research. This article distills actionable experimental protocols, troubleshooting strategies, and advanced workflow tips, leveraging both cutting-edge metabolomics and established immunology paradigms for reproducibility and maximum scientific impact.

• Bufalin Targets STK33 to Inhibit Triple-Negative Breast Canc

  2026-05-04

  This study identifies serine/threonine kinase 33 (STK33) as a direct molecular target of Bufalin in triple-negative breast cancer (TNBC). By elucidating Bufalin's mechanism of degrading STK33 and inhibiting TNBC cell proliferation, the research offers a promising therapeutic direction for aggressive breast cancer subtypes.

• DiscoveryProbe™ FDA-approved Drug Library in Neurotherapeuti

  2026-05-03

  Explore how the DiscoveryProbe FDA-approved Drug Library enables neurodegenerative disease drug discovery and target identification, featuring real-world assay strategies and unique evidence from recent luminescence-based screening advances.

15870 records 1/1058 page Next 12345 下5页 Last page